Living Longer But Losing Our Minds: The Alzheimer’s Emergency

Thanks to medical advances, we’re living longer lives but with that comes rising rates of Alzheimer’s. However, emerging new drugs have the ability to slow cognitive decline—giving hope to millions.

Episode two of season four explores the history of Alzheimer’s, its current challenges, and the promising therapies at the forefront of innovation and investment. You’ll hear from:

• Dr. Asa Abeliovich, Neurologist, Molecular Geneticist, and Founder and CEO at Leal Therapeutics
• Carl Gordon, Managing Partner and Head of Global Private Equity at OrbiMed
• Ham Lee, Co-Head of Healthcare Practice at Cambridge Associates
• Randi Casciano, Director of Global Public Relations at Cambridge Associates

Listen below or wherever you get your podcasts.